Latest On-Demand Webinars

Oligonucleotide therapeutics such as antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) are becoming increasingly important due to their high specificity and capability for treating formerly undruggable targets.

This webinar will outline how Boss' lab used CN Bio’s Toxicity Testing Services to investigate the hepatotoxicity of two cobinamide formulations. Dr. Boss will discuss the results of the research, study and how the work informed which formulations of cobinamide could be safe for humans.

Watch this webinar to learn more about how the use of triple quadrupole GC/MS for routine dioxin analysis can improve your lab’s productivity, eurofins carries out dioxin analysis in environmental samples with performance criteria and the use of hydrogen carrier gas can significantly reduce lab operating costs.

Watch this webinar to learn more about how high-resolution GC/Q-TOF exceeds regulatory performance requirement, the targeted and untargeted screening workflow capabilities of quadrupole time-of-flight GC/MS and how GC/Q-TOF mass spectrometry can increase your lab’s productivity.

Watch this webinar to learn more about recent innovations in GC/MS technologies,
key parameters for success with the purge and trap method and an efficient way to build both the quantitation method and VOCs library using spectral deconvolution.

As organizations look to build and execute digital transformation strategies, a major focus is how to improve the scientific experience. To maximize the output of the lab, scientists need to be able to rely on technological advancements, innovative software and improved processes.

Even with robust quality systems governing your analytical laboratory and a strong data integrity (DI) program in place, you may still be nervous about preparing for a regulatory inspection. What will the inspectors want to know? What will they ask? Is your team prepared?

As we all know, current global research efforts are focused on understanding the SARS-CoV-2 virus. Developing vaccines and therapies to combat the virus has become a priority, laboratories are addressing research questions at key stages in viral infectivity workflows.

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

To gain a more comprehensive view of complex disorders of the human brain, researchers need innovative technologies to discover new insights at the molecular, cellular and tissue levels.